|1.||Gohil, N K: 1 article (01/2015)|
|2.||Nirala, B K: 1 article (01/2015)|
|3.||Delafontaine, Jean-Luc: 1 article (01/2013)|
|4.||Venkatesan, Balachandar: 1 article (01/2013)|
|5.||Siebenlist, Ulrich: 1 article (01/2013)|
|6.||Das, Nitin A: 1 article (01/2013)|
|7.||Carpenter, Andrea J: 1 article (01/2013)|
|8.||Chandrasekar, Bysani: 1 article (01/2013)|
|9.||Valente, Anthony J: 1 article (01/2013)|
|10.||Yoshida, Tadashi: 1 article (01/2013)|
10/01/2012 - "On the other hand sICAM-1 was up-regulated by AGE-HSA but down-regulated by hypoxia. "
10/01/2012 - "However, when the cells were exposed to a combination treatment of hypoxia and AGE-HSA, a biphasic effect at the two different concentrations was observed as compared to the individual treatments. "
10/01/2012 - "VEGF was synergistically up-regulated by hypoxia and AGE-HSA. "
10/01/2012 - "Therefore we have examined the interaction of glycation modified human serum albumin (AGE-HSA) and deferoxamine (DFO) mimicked hypoxia on the expression of hypoxia inducible factor 1α (HIF-1α), and the role of RAGE (receptor for AGE) signaling in up-regulation of HIF-1α. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Galectin 3 (LGALS3)
|3.||NF-kappa B (NF-kB)
|7.||oxidized low density lipoprotein